Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cordlife Group ( (SG:P8A) ) has issued an update.
Cordlife Group Limited has submitted written representations to the Ministry of Health (MOH) regarding the potential suspension of its cord blood banking service license. The company has been granted an extension to provide these representations and will update stakeholders on the outcome as it becomes available, advising caution for shareholders and potential investors in the meantime.
More about Cordlife Group
Cordlife Group Limited is a company based in Singapore, operating in the healthcare industry with a focus on cord blood and human tissue banking services.
YTD Price Performance: -1.33%
Average Trading Volume: 40,238
Technical Sentiment Signal: Strong Sell
Current Market Cap: S$37.78M
For a thorough assessment of P8A stock, go to TipRanks’ Stock Analysis page.